Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients

被引：6

作者：

Kamper, AM ^{[1
]}

Lins, RL ^{[1
]}

Zachee, P ^{[1
]}

VanBergen, S ^{[1
]}

Hosten, S ^{[1
]}

Daelemans, R ^{[1
]}

机构：

[1] AZ STUIVENBERG,DEPT NEPHROL HYPERTENS,B-2060 ANTWERP,BELGIUM

来源：

NEPHRON | 1997年 / 77卷 / 04期

关键词：

D O I：

10.1159/000190330

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：484 / 485

页数：2

共 7 条

[1] THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE [J].

GENT, M ;

EASTON, JD ;

HACHINSKI, VC ;

PANAK, E ;

SICURELLA, J ;

BLAKELY, JA ;

ELLIS, DJ ;

HARBISON, JW ;

ROBERTS, RS ;

TURPIE, AGG .

LANCET, 1989, 1 (8649) :1215-1220

[2] THROMBOPROPHYLACTIC EFFECT OF TICLOPIDINE IN ARTERIOVENOUS-FISTULAS FOR HEMODIALYSIS [J].

GRONTOFT, KC ;

MULEC, H ;

GUTIERREZ, A ;

OLANDER, R .

SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1985, 19 (01) :55-57

[3] Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients [J].

Janssen, MJFM ;

Deegens, JK ;

Kapinga, TH ;

Beukhof, JR ;

Huijgens, PC ;

vanLoenen, AC ;

vanderMeulen, J .

KIDNEY INTERNATIONAL, 1996, 49 (03) :806-813

[4]

JEFFREY RF, 1993, ARTIF ORGANS, V17, P717

[5]

KOBAYASHI K, 1980, IGAKU NO AYUMI, V112, P294

[6]

Nurmohamed M T, 1991, ASAIO Trans, V37, pM459

[7] COMPARISON OF LOW-MOLECULAR WEIGHT HEPARIN TO STANDARD HEPARIN IN HEMODIALYSIS HEMOFILTRATION [J].

SCHRADER, J ;

STIBBE, W ;

ARMSTRONG, VW ;

KANDT, M ;

MUCHE, R ;

KOSTERING, H ;

SEIDEL, D ;

SCHELER, F .

KIDNEY INTERNATIONAL, 1988, 33 (04) :890-896

← 1 →